The use of modified bite block to improve the safety and efficacy of oral fiber optic intubation in patients with limited neck mobility: a randomized comparative study

AbstractThis was a double-blind randomized study to compare the safety and efficacy of timethoprim-polymyxin B (TP) and trimethoprim-sulfacetamide-polymyxin B (TSP) drops in the treatment of otorrhea. The 68 cases treated suffered from external otitis, recurrent otitis, recurrent otitis media with tympanic membrance perforation, or infected mastoid cavities and post-operative tympanoplasties. The TP ototopical solution was successful in 60·6 per cent of cases compared to 88·6 per cent of cases with TSP. These rates were statistically different using the Chi Square with Yates' correction method.There were no sings of ototoxicity, fungal infection overgrowth or local sensitivity to either of the solutions.The study has shown that both drugs are equally safe and that TSP is significantly more effective in the treatment of otorrhea.

Download Full-text

A COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF INTRA VAGINAL MISOPROSTOL TABLET VERSUS INTRA CERVICAL DINOPROSTONE GEL FOR CERVICAL RIPENING AND INDUCTION OF LABOUR

Journal of Evolution of Medical and Dental Sciences ◽

10.14260/jemds/2015/253 ◽

2015 ◽

Vol 04 (11) ◽

pp. 1769-1775

Author(s):

Madhavi K N ◽

◽

Polaiah K P ◽

Thokala Sivaiah

Keyword(s):

Comparative Study ◽

Induction Of Labour ◽

Cervical Ripening ◽

Safety And Efficacy ◽

Vaginal Misoprostol

Download Full-text

One-Year Visual and Refractive Outcomes following LASIK for Myopia and Myopic Astigmatism with MEL 90 versus Schwind Amaris 750S Excimer Laser: A Comparative Study

Journal of Ophthalmology ◽

10.1155/2021/9929181 ◽

2021 ◽

Vol 2021 ◽

pp. 1-10

Author(s):

Sheetal Brar ◽

Dishitha P. Rathod ◽

C. R. Roopashree ◽

Sri Ganesh

Keyword(s):

Comparative Study ◽

Clinical Outcomes ◽

Excimer Laser ◽

Infectious Keratitis ◽

Safety And Efficacy ◽

Refractive Outcomes ◽

The Mean ◽

One Year ◽

Myopic Astigmatism

Purpose. To compare clinical outcomes following LASIK for myopia performed with MEL 90 vs. Schwind Amaris 750S excimer laser. Methods. Data were collected retrospectively for patients who underwent Femto-LASIK, using the MEL 90 and Schwind Amaris 750S excimer laser for correction of myopia and myopic astigmatism within the range of −1.00 to −10.00 D SE from January 2013 till June 2018. Outcomes were analysed at 12 months for safety, efficacy, enhancement rate, and long-term complications. Results. A total of 328 eyes of 328 patients were analysed. One hundred and sixty-three eyes were treated with Schwind Amaris and the remaining 165 eyes with the MEL 90 laser. Twelve months postoperatively, the mean UDVA, CDVA, residual SE, and cylinder in the Amaris group were −0.10 ± 0.09 logMAR, −0.14 ± 0.06 logMAR, −0.21 ± 0.22 D, −0.13 ± 0.18 D versus −0.05 ± 0.07 logMAR, −0.09 ± 0.08 logMAR, −0.23 ± 0.23 D, and −0.14 ± 0.21 D for the MEL 90 group ( p values >0.05). For the Amaris group, safety and efficacy indices were 1.12 and 1.02, whereas for the MEL 90 group, these indices were 1.08 and 1.00, respectively. No eye in either group had any postop flap-related complications, infectious keratitis, diffuse lamellar keratitis, or keratectasia. Two eyes in the Amaris and 4 eyes in MEL 90 group required enhancement for the progression of myopia. Conclusion. At 12 months, both Schwind Amaris 750S and MEL 90 lasers demonstrated comparable clinical outcomes for myopic LASIK in a single surgeon setting.

Download Full-text